These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 2122616)

  • 21. GM2-ganglioside metabolism in cultured human skin fibroblasts: unambiguous diagnosis of GM2-gangliosidosis.
    Raghavan S; Krusell A; Lyerla TA; Bremer EG; Kolodny EH
    Biochim Biophys Acta; 1985 Apr; 834(2):238-48. PubMed ID: 3995063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pathology of Sandhoff's disease.
    Hadfield MG; Mamunes P; David RB
    J Pathol; 1977 Nov; 123(3):137-44. PubMed ID: 592019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultrastructural study of biopsy specimens of rectal mucosa. Its use in neuronal storage diseases.
    Yamano T; Shimada M; Okada S; Yutaka T; Kato T; Yabuuchi H
    Arch Pathol Lab Med; 1982 Dec; 106(13):673-7. PubMed ID: 6897182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurophysiological investigations in GM1 and GM2 gangliosidoses.
    Pampiglione G; Harden A
    Neuropediatrics; 1984 Sep; 15 Suppl():74-84. PubMed ID: 6100798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracellular degradation of sulforhodamine-GM1: use for a fluorescence-based characterization of GM2-gangliosidosis variants in fibroblasts and white blood cells.
    Agmon V; Khosravi R; Marchesini S; Dinur T; Dagan A; Gatt S; Navon R
    Clin Chim Acta; 1996 Mar; 247(1-2):105-20. PubMed ID: 8920231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Manifestation of infantile GM1 gangliosidosis in the fetal eye. An electron microscopic study.
    Schmitt-Gräff A
    Graefes Arch Clin Exp Ophthalmol; 1988; 226(1):84-8. PubMed ID: 3125087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prenatal diagnosis of GM2 gangliosidosis with high residual hexosaminidase A activity (variant B1; pseudo AB variant).
    Conzelmann E; Nehrkorn H; Kytzia HJ; Sandhoff K; Macek M; Lehovský M; Elleder M; Jirásek A; Kobilková J
    Pediatr Res; 1985 Nov; 19(11):1220-4. PubMed ID: 2933632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis.
    Sango K; McDonald MP; Crawley JN; Mack ML; Tifft CJ; Skop E; Starr CM; Hoffmann A; Sandhoff K; Suzuki K; Proia RL
    Nat Genet; 1996 Nov; 14(3):348-52. PubMed ID: 8896570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B1 variant of GM2 gangliosidosis in a 12-year-old patient.
    Goebel HH; Stolte G; Kustermann-Kuhn B; Harzer K
    Pediatr Res; 1989 Jan; 25(1):89-93. PubMed ID: 2521932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accumulation of ganglioside Gm2 in cerebrospinal fluid of a patient with the variant AB of infantile Gm2 gangliosidosis.
    Pullarkat RK; Reha H; Beratis NG
    Pediatrics; 1981 Jul; 68(1):106-8. PubMed ID: 7243492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of microtechniques for the detection of lysosomal enzyme disorders: Tay-Sachs disease, Gm1-gangliosidosis and Fabry disease.
    Bladon MT; Milunsky A
    Clin Genet; 1978 Dec; 14(6):359-66. PubMed ID: 215359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prenatal diagnosis of hereditary lysosomal diseases].
    Mirenburg TV; Aronovich EL; Lebedeva TV; Akhunov VS; Krasnopol'skaia KD
    Vopr Med Khim; 1988; 34(4):41-6. PubMed ID: 3143186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The gangliosidoses: comparative features and research applications.
    Baker HJ; Reynolds GD; Walkley SU; Cox NR; Baker GH
    Vet Pathol; 1979 Nov; 16(6):635-49. PubMed ID: 116415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Sandhoff disease in a Thai family: clinical and biochemical characterization.
    Sakpichaisakul K; Taeranawich P; Nitiapinyasakul A; Sirisopikun T
    J Med Assoc Thai; 2010 Sep; 93(9):1088-92. PubMed ID: 20873083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of GM2-gangliosidosis (Tay-Sachs and Sandhoff disease) gene carriers by serum hexosaminidase assay.
    Molzer B; Bernheimer H
    Clin Chim Acta; 1976 Nov; 73(1):163-9. PubMed ID: 826357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical outcome assessments of disease burden and progression in late-onset GM2 gangliosidoses.
    Kissell J; Rochmann C; Minini P; Eichler F; Stephen CD; Lau H; Toro C; Johnston JM; Krupnick R; Hamed A; Cox GF
    Mol Genet Metab; 2024 Jul; 142(3):108512. PubMed ID: 38870773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GM2 gangliosidoses: a review of cases confirmed by beta-N-acetylhexosaminidase assay.
    Christopher R; Rangaswamy GR; Shetty KT
    Indian J Pediatr; 1995; 62(4):479-83. PubMed ID: 10829909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gangliosidoses.
    Patterson MC
    Handb Clin Neurol; 2013; 113():1707-8. PubMed ID: 23622392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Presence of beta-hexosaminidase A alpha-chain mRNA in two different variants of GM2-gangliosidosis.
    Budde-Steffen C; Steffen M; Siegel DA; Suzuki K
    Neuropediatrics; 1988 May; 19(2):59-61. PubMed ID: 2967444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr virus transformed lymphoid cell lines as a new model system in culture for the study of GM2-gangliosidoses: Tay-Sachs and Sandhoff diseases.
    Maret A; Salvayre R; Negre A; Bes JC; Douste-Blazy L
    Biol Cell; 1985; 53(3):293-6. PubMed ID: 2990625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.